Loading...

Philip Hopewell, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-206-8313
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency

    Collapse Research 
    Collapse Research Activities and Funding
    Tuberculosis epidemiology and novel transmission routes in rural Tanzania
    NIH/NIAID U01AI088679Jul 7, 2010 - Jun 30, 2015
    Role: Principal Investigator
    Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi
    NIH/NIAID R01AI076476Aug 28, 2009 - Jul 31, 2014
    Role: Principal Investigator
    MALABSORPTION OF ANTITUBERCULOUS DRUGS IN BOTSWANA
    NIH/FIC R03TW000860Sep 30, 1997 - Jun 30, 2000
    Role: Principal Investigator
    Population Based Molecular epidemiology of Tuberculosis
    NIH/NIAID R01AI034238Apr 1, 1993 - Aug 31, 2012
    Role: Principal Investigator
    PULMONARY COMPLICATIONS OF HIV INFECTION
    NIH/NHLBI U01HL048501Sep 30, 1992 - May 31, 1996
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gordon SB, Buist AS, Hopewell P, Pinkerton K, Sly P, West TE, Moschovis P, Accinelli RA, Cruz ÁA, Adhikari NKJ. How Do We "Help the World Breathe"? Am J Respir Crit Care Med. 2017 Nov 01; 196(9):1100-1102. PMID: 29090965.
      View in: PubMed
    2. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 03 09; 12(1):33. PMID: 28274245.
      View in: PubMed
    3. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell P, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 Oct 01; 63(7):853-67. PMID: 27621353.
      View in: PubMed
    4. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell P, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 Oct 01; 63(7):e147-e195. PMID: 27516382.
      View in: PubMed
    5. Murray JF, Schraufnagel DE, Hopewell P. Treatment of Tuberculosis. A Historical Perspective. Ann Am Thorac Soc. 2015 Dec; 12(12):1749-59. PMID: 26653188.
      View in: PubMed
    6. Murray JF, Hopewell P. Giants in Chest Medicine: John F. Murray, MD. Chest. 2015 Nov; 148(5):1123-1125. PMID: 26527434.
      View in: PubMed
    7. Chakaya JM, Carter EJ, Hopewell P. Pulmonary specialty training to improve respiratory health in low- and middle-income countries. Needs and challenges. Ann Am Thorac Soc. 2015 Apr; 12(4):486-90. PMID: 25714500.
      View in: PubMed
    8. Metcalfe JZ, Makumbirofa S, Makamure B, Mutetwa R, Peñaloza RA, Sandy C, Bara W, Mungofa S, Hopewell P, Mason P. Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients. Eur Respir J. 2015 May; 45(5):1504-6. PMID: 25792637; PMCID: PMC4948946.
    9. Metcalfe JZ, Vittinghoff E, Hopewell P. Analysis of Green Light Committee implementation and acquisition of second-line drug resistance. Clin Infect Dis. 2015 Mar 15; 60(6):970. PMID: 25527651.
      View in: PubMed
    10. Suwanpimolkul G, Grinsdale JA, Jarlsberg LG, Higashi J, Osmond DH, Hopewell P, Kato-Maeda M. Association between diabetes mellitus and tuberculosis in United States-born and foreign-born populations in San Francisco. PLoS One. 2014; 9(12):e114442. PMID: 25478954; PMCID: PMC4257695.
    11. Metcalfe JZ, Mason P, Mungofa S, Sandy C, Hopewell P. Empiric tuberculosis treatment in retreatment patients in high HIV/tuberculosis-burden settings. Lancet Infect Dis. 2014 Sep; 14(9):794-5. PMID: 25164190; PMCID: PMC4317243.
    12. Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell P, Cattamanchi A. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1551-9. PMID: 24869625; PMCID: PMC4226012.
    13. Budzik JM, Jarlsberg LG, Higashi J, Grinsdale J, Hopewell P, Kato-Maeda M, Nahid P. Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California. PLoS One. 2014; 9(4):e95645. PMID: 24759760; PMCID: PMC3997554.
    14. Hopewell P, Fair EL, Uplekar M. Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. Ann Am Thorac Soc. 2014 Mar; 11(3):277-85. PMID: 24673691.
      View in: PubMed
    15. Hopewell P. Updating the international standards for tuberculosis care. Int J Tuberc Lung Dis. 2014 Mar; 18(3):253. PMID: 24670556.
      View in: PubMed
    16. Pai M, Satyanarayana S, Hopewell P. Improving quality of tuberculosis care in India. Indian J Tuberc. 2014 Jan; 61(1):12-8. PMID: 24640340.
      View in: PubMed
    17. Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell P, Mason P. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014 Jan; 20(1):135-7. PMID: 24377879; PMCID: PMC3884722.
    18. Prach LM, Pascopella L, Barry PM, Flood J, Porco TC, Hopewell P, Metcalfe JZ. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study. AIDS. 2013 Oct 23; 27(16):2615-22. PMID: 23842135; PMCID: PMC4296030.
    19. Ukwaja KN, Alobu I, Lgwenyi C, Hopewell P. The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PLoS One. 2013; 8(8):e73134. PMID: 24015293; PMCID: PMC3754914.
    20. Hopewell P. We help the world breathe. Ann Am Thorac Soc. 2013 Aug; 10(4):357-8. PMID: 23952855.
      View in: PubMed
    21. Suwanpimolkul G, Jarlsberg LG, Grinsdale JA, Osmond D, Kawamura LM, Hopewell P, Kato-Maeda M. Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco. Am J Respir Crit Care Med. 2013 May 01; 187(9):998-1006. PMID: 23471470; PMCID: PMC3707362.
    22. Kato-Maeda M, Ho C, Passarelli B, Banaei N, Grinsdale J, Flores L, Anderson J, Murray M, Rose G, Kawamura LM, Pourmand N, Tariq MA, Gagneux S, Hopewell P. Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak. PLoS One. 2013; 8(3):e58235. PMID: 23472164; PMCID: PMC3589338.
    23. Metcalfe JZ, Porco TC, Westenhouse J, Damesyn M, Facer M, Hill J, Xia Q, Watt JP, Hopewell P, Flood J. Tuberculosis and HIV co-infection, California, USA, 1993–2008. Emerg Infect Dis. 2013 Mar; 19(3):400-6. PMID: 23745218; PMCID: PMC3648844.
    24. Davis JL, Cattamanchi A, Cuevas LE, Hopewell P, Steingart KR. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013 Feb; 13(2):147-54. PMID: 23099183; PMCID: PMC3836432.
    25. Murray JF, Du Melle F, Hopewell P. Evolution and revolution: the formation of today's American Thoracic Society, part 1. Am J Respir Crit Care Med. 2012 Nov 15; 186(10):948-52. PMID: 22822021.
      View in: PubMed
    26. Hopewell P, Du Melle F, Murray JF. Evolution and revolution: the formation of Today's American Thoracic Society, Part 2. Am J Respir Crit Care Med. 2012 Dec 01; 186(11):1082-6. PMID: 22822018.
      View in: PubMed
    27. Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Barrozo JC, Rose J, Kawamura LM, Coscolla M, Fofanov VY, Koshinsky H, Gagneux S, Hopewell P, Ordway DJ, Orme IM. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin Vaccine Immunol. 2012 Aug; 19(8):1227-37. PMID: 22718126; PMCID: PMC3416080.
    28. Dantes R, Metcalfe J, Kim E, Kato-Maeda M, Hopewell P, Kawamura M, Nahid P, Cattamanchi A. Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis. PLoS One. 2012; 7(5):e37956. PMID: 22649569; PMCID: PMC3359338.
    29. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell P, Pai M. Interferon-? release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis. 2011 Nov 15; 204 Suppl 4:S1120-9. PMID: 21996694; PMCID: PMC3192542.
    30. Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, Ramsay A, Hopewell P, Pai M. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med. 2011 Aug; 8(8):e1001062. PMID: 21857806; PMCID: PMC3153457.
    31. Nahid P, Horne DJ, Jarlsberg LG, Reiner AP, Osmond D, Hopewell P, Bibbins-Domingo K. Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study. Clin Infect Dis. 2011 Aug 01; 53(3):291-4. PMID: 21765079; PMCID: PMC3137794.
    32. Davis J, Katamba A, Vasquez J, Crawford E, Sserwanga A, Kakeeto S, Kizito F, Dorsey G, den Boon S, Vittinghoff E, Huang L, Adatu F, Kamya MR, Hopewell P, Cattamanchi A. Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. Am J Respir Crit Care Med. 2011 Aug 01; 184(3):362-7. PMID: 21471088; PMCID: PMC3175538.
    33. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell P, Pai M. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011 Mar 01; 56(3):230-8. PMID: 21239993; PMCID: PMC3383328.
    34. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell P, Daley CL. Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis. 2011 Jan 03; 11:1. PMID: 21199579; PMCID: PMC3022714.
    35. Cattamanchi A, Huang L, Worodria W, den Boon S, Kalema N, Katagira W, Byanyima P, Yoo S, Matovu J, Hopewell P, Davis JL. Integrated strategies to optimize sputum smear microscopy: a prospective observational study. Am J Respir Crit Care Med. 2011 Feb 15; 183(4):547-51. PMID: 20851925; PMCID: PMC3056227.
    36. Metcalfe JZ, Kim EY, Lin SY, Cattamanchi A, Oh P, Flood J, Hopewell P, Kato-Maeda M. Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. Emerg Infect Dis. 2010 Sep; 16(9):1403-9. PMID: 20735924; PMCID: PMC3294976.
    37. Horne DJ, Royce SE, Gooze L, Narita M, Hopewell P, Nahid P, Steingart KR. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis. 2010 Jun; 10(6):387-94. PMID: 20510279; PMCID: PMC3046810.
    38. Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell P, Kato-Maeda M. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010 May 20; 5(5):e10753. PMID: 20505778; PMCID: PMC2873999.
    39. Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, den Boon S, Yoo S, Andama A, Hopewell P, Cao H. Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis. 2010 Mar 20; 10:75. PMID: 20302657; PMCID: PMC2846947.
    40. Kim EY, Nahid P, Hopewell P, Kato-Maeda M. Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis. J Clin Microbiol. 2010 Apr; 48(4):1422-4. PMID: 20147648; PMCID: PMC2849554.
    41. Flores L, Jarlsberg LG, Kim EY, Osmond D, Grinsdale J, Kawamura M, Desmond E, Hopewell P, Kato-Maeda M. Comparison of restriction fragment length polymorphism with the polymorphic guanine-cytosine-rich sequence and spoligotyping for differentiation of Mycobacterium tuberculosis isolates with five or fewer copies of IS6110. J Clin Microbiol. 2010 Feb; 48(2):575-8. PMID: 20032250; PMCID: PMC2815604.
    42. Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell P, Kawamura LM, Nahid P. Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med. 2010 Jan 01; 181(1):87-93. PMID: 19797760; PMCID: PMC2797629.
    43. Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell P, Wells CD, Reingold AL, Kenyon TA, Moeti TL, Tappero JW. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis. 2009 Jun 15; 48(12):1685-94. PMID: 19432554; PMCID: PMC3762461.
    44. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, Joloba M, Matovu J, Hopewell P, Huang L. Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis. 2009 May 06; 9:53. PMID: 19419537; PMCID: PMC2690598.
    45. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell P, Nahid P. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis. 2009 Jan 15; 48(2):179-85. PMID: 19086909; PMCID: PMC2756509.
    46. Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell P, Ramsay A, Pai M, Laal S. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol. 2009 Feb; 16(2):260-76. PMID: 19052159; PMCID: PMC2643545.
    47. Morrison J, Pai M, Hopewell P. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008 Jun; 8(6):359-68. PMID: 18450516.
      View in: PubMed
    48. Walter ND, Jasmer RM, Grinsdale J, Kawamura LM, Hopewell P, Nahid P. Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective. Clin Infect Dis. 2008 Jan 01; 46(1):103-6. PMID: 18171222.
      View in: PubMed
    49. Wu B, Huang C, Kato-Maeda M, Hopewell P, Daley CL, Krensky AM, Clayberger C. IL-24 modulates IFN-gamma expression in patients with tuberculosis. Immunol Lett. 2008 Apr 15; 117(1):57-62. PMID: 18199488; PMCID: PMC2679252.
    50. Wu B, Huang C, Kato-Maeda M, Hopewell P, Daley CL, Krensky AM, Clayberger C. IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol. 2008 Feb; 126(2):202-10. PMID: 18032114.
      View in: PubMed
    51. Steingart KR, Henry M, Laal S, Hopewell P, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Postgrad Med J. 2007 Nov; 83(985):705-12. PMID: 17989270; PMCID: PMC2734443.
    52. Boulware DR, Daley CL, Merrifield C, Hopewell P, Janoff EN. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J Infect. 2007 Oct; 55(4):300-9. PMID: 17692384; PMCID: PMC2039755.
    53. DeRiemer K, Kawamura LM, Hopewell P, Daley CL. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med. 2007 Nov 01; 176(9):936-44. PMID: 17690336; PMCID: PMC2048673.
    54. Steingart KR, Henry M, Laal S, Hopewell P, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax. 2007 Oct; 62(10):911-8. PMID: 17675320; PMCID: PMC2094240.
    55. Steingart KR, Henry M, Laal S, Hopewell P, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 2007 Jun; 4(6):e202. PMID: 17564490; PMCID: PMC1891320.
    56. Wu B, Huang C, Kato-Maeda M, Hopewell P, Daley CL, Krensky AM, Clayberger C. Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol. 2007 Mar 15; 178(6):3688-94. PMID: 17339466; PMCID: PMC2679258.
    57. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell P, Daley CL. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med. 2007 Jun 01; 175(11):1199-206. PMID: 17290042; PMCID: PMC1899273.
    58. Fair E, Hopewell P, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther. 2007 Feb; 5(1):61-5. PMID: 17266454.
      View in: PubMed
    59. Hopewell P, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis. 2006 Nov; 6(11):710-25. PMID: 17067920.
      View in: PubMed
    60. Steingart KR, Ng V, Henry M, Hopewell P, Ramsay A, Cunningham J, Urbanczik R, Perkins MD, Aziz MA, Pai M. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006 Oct; 6(10):664-74. PMID: 17008175.
      View in: PubMed
    61. Steingart KR, Henry M, Ng V, Hopewell P, Ramsay A, Cunningham J, Urbanczik R, Perkins M, Aziz MA, Pai M. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006 Sep; 6(9):570-81. PMID: 16931408.
      View in: PubMed
    62. Hopewell P, Migliori GB, Raviglione MC. Tuberculosis care and control. Bull World Health Organ. 2006 Jun; 84(6):428. PMID: 16799719; PMCID: PMC2627365.
    63. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell P, Small PM. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2869-73. PMID: 16477032; PMCID: PMC1413851.
    64. Nahid P, Pai M, Hopewell P. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006; 3(1):103-10. PMID: 16493157; PMCID: PMC2658675.
    65. Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman S, Oyewo A, Talbot EA, Kenyon TA, Moeti TL, Moffat HJ, Peloquin CA. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis. 2005 Aug 15; 41(4):461-9. PMID: 16028152.
      View in: PubMed
    66. Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell P. Imipenem for treatment of tuberculosis in mice and humans. Antimicrob Agents Chemother. 2005 Jul; 49(7):2816-21. PMID: 15980354; PMCID: PMC1168716.
    67. Hopewell P, Pai M. Tuberculosis, vulnerability, and access to quality care. JAMA. 2005 Jun 08; 293(22):2790-3. PMID: 15941811.
      View in: PubMed
    68. Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell P, Daley CL. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clin Infect Dis. 2005 Apr 01; 40(7):968-75. PMID: 15824988.
      View in: PubMed
    69. Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell P, Bernardo J, King MD, Kawamura LM, Daley CL. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial. Clin Infect Dis. 2004 Feb 01; 38(3):363-9. PMID: 14727206.
      View in: PubMed
    70. Burgos M, DeRiemer K, Small PM, Hopewell P, Daley CL. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis. 2003 Dec 15; 188(12):1878-84. PMID: 14673768.
      View in: PubMed
    71. Ong A, Creasman J, Hopewell P, Gonzalez LC, Wong M, Jasmer RM, Daley CL. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004 Jan 01; 38(1):25-31. PMID: 14679444.
      View in: PubMed
    72. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell P, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003 Feb 15; 167(4):603-62. PMID: 12588714.
      View in: PubMed
    73. Jasmer RM, Nahid P, Hopewell P. Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002 Dec 05; 347(23):1860-6. PMID: 12466511.
      View in: PubMed
    74. Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell P. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med. 2002 Oct 15; 137(8):640-7. PMID: 12379063.
      View in: PubMed
    75. Hopewell P. Tuberculosis control: how the world has changed since 1990. Bull World Health Organ. 2002; 80(6):427. PMID: 12131995; PMCID: PMC2567528.